Advertisement

Tumor Biology

, Volume 32, Issue 1, pp 129–138 | Cite as

Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity

  • Gargi Maity
  • Paromita Roy Choudhury
  • Triparna Sen
  • Kirat Kumar Ganguly
  • Hrishikesh Sil
  • Amitava Chatterjee
Research Article

Abstract

Interaction between cell surface integrin receptors with extracellular matrix (ECM) plays an important role in cell survival, proliferation, and migration including tumor development and invasion. Binding of ECM to integrins initiates intracellular signaling cascades, modulating expression and activity of different matrix metalloproteinases (MMPs) which is important in ECM degradation. The present study investigates fibronectin–integrin-mediated signaling and thereby modulation of MMPs expression and activity in human breast cancer cell line, MDA-MB-231. Culture of MDA-MB-231 cells on fibronectin (FN) induced expression and activity of pro-matrixmetalloproteinase-9 (MMP-9). Appreciable reduction of FN-induced pro-MMP-9 activity was observed in anti-α5 antibody treated cells. Inhibitor studies revealed that inhibitors of phosphatidyl inositiol-3-kinase (PI-3K), and nuclear factor kappa B (NF-κB) inhibited FN-induced pro-MMP-9 activity. FN increased tyrosine phosphorylation of focal adhesion kinase (FAK), integrin linked kinase (ILK), and PI-3K in MDA-MB-231 cells. FN-induced the transactivation of MMP-9 promoter by enhancing DNA binding activity of NF-κB and Sp1. Wound healing assay showed faster migration of MDA-MB-231cells grown on fibronectin-coated as surface as compared to control. Our findings indicated that culture of MDA-MB-231 on fibronectin perhaps send signals via fibronectin–integrin-mediated signaling pathways recruiting FAK, PI-3K, ILK, NF-κB, and modulate expression and activation of pro-MMP-9. These observations may enrich fundamental aspects of cancer biology especially role of α5β1 integrin in regulation of MMPs expression and activity.

Keywords

FAK Fibronectin ILK MDA-MB-231 MMP-9 NF-κB PI-3K 

Notes

Acknowledgments

We acknowledge the Director of the Chittaranjan National Cancer Institute for Institute facilities and financial support, and the Indian Council for Medical Research (ICMR), New Delhi, India (Grant No. 5/13/49/05/NCD-III) for financial support.

Conflicts of interest

All authors hereby disclose that they do not have any financial and/or personal relationships with other people of organization that could in appropriately influence (bias) their work. The authors declare that “there are no conflicts of interest”.

References

  1. 1.
    Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999;189:300–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161–74.CrossRefPubMedGoogle Scholar
  3. 3.
    Morrow PK, Kim ES. New biological agents in the treatment of advanced non-small cell lung cancer. Semin Respir Crit Care Med. 2005;26:323–32.CrossRefPubMedGoogle Scholar
  4. 4.
    Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25:9–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD, Yang F, et al. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer. 2008;122:2050–6.CrossRefPubMedGoogle Scholar
  6. 6.
    La Rocca G, Pucci-Minafra I, Marrazzo A, Taormina P, Minafra S. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer. 2004;90:1414–21.CrossRefPubMedGoogle Scholar
  7. 7.
    Torbenson M, Wang J, Choti M, Ashfaq R, Maitra A, Wilentz RE, et al. Hepatocellular carcinomas show abnormal expression of fibronectin protein. Mod Pathol. 2002;15:826–30.CrossRefPubMedGoogle Scholar
  8. 8.
    Han S, Ritzenthaler JD, Wingerd B, Rivera HN, Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem. 2006;281:29614–24.CrossRefPubMedGoogle Scholar
  9. 9.
    Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:9482–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res. 2002;62:283–9.PubMedGoogle Scholar
  11. 11.
    Bartsch JE, Staren ED, Appert HE. Matrix metalloproteinase expression in breast cancer. J Surg Res. 2003;110:383–92.CrossRefPubMedGoogle Scholar
  12. 12.
    Jia Y, Zeng ZZ, Markwart SM, Rockwood KF, Ignatoski KM, Ethier SP, et al. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Res. 2004;64:8674–81.CrossRefPubMedGoogle Scholar
  13. 13.
    Das S, Banerji A, Frei E, Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci. 2008;82:467–76.CrossRefPubMedGoogle Scholar
  14. 14.
    Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT, et al. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis. 2000;18:423–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Maity G, Fahreen S, Banerji A, Roy Choudhury P, Sen T, Dutta A, et al. Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa). Mol Cell Biochem. 2010;336:65–74.CrossRefPubMedGoogle Scholar
  16. 16.
    Banerji A, Das S, Chatterjee A. Culture of human A375 melanoma cells in the presence of fibronectin causes expression of MMP-9 and activation of MMP-2 in culture supernatants. J Environ Pathol Toxicol Oncol. 2008;27:135–45.PubMedGoogle Scholar
  17. 17.
    Maity G, Sen T, Chatterjee A. Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell (SiHa). J Cancer Res Clin Oncol. 2010; (PMID: 20425121).Google Scholar
  18. 18.
    Sen T, Moulik S, Dutta A, Roy Choudhury P, Banerji A, Das S, et al. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci. 2009;84:194–204.CrossRefPubMedGoogle Scholar
  19. 19.
    Bannikov GA, Karelina TV, Collier IE, Marmer BL, Goldberg GI. Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem. 2002;277:16022–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000;1477:267–83.PubMedGoogle Scholar
  21. 21.
    Munshi HG, Stack MS. Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev. 2006;25:45–56.CrossRefPubMedGoogle Scholar
  22. 22.
    Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fassler R. Intergins in invasive growth. J Clin Invest. 2002;109:999–1006.PubMedGoogle Scholar
  23. 23.
    Shibata K, Kikkawa F, Nawa A, Tamakoshi K, Suganuma N, Tomoda Y. Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue. Clin Exp Metastasis. 1997;15:612–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Sawhney RS, Cookson MM, Omar Y, Hauser J, Brattain MG. Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway. J Biol Chem. 2006;281:8497–510.CrossRefPubMedGoogle Scholar
  25. 25.
    Ossovskaya V, Lim ST, Ota N, Schlaepfer DD, Ilic D. FAK nuclear export signal sequences. FEBS Lett. 2008;582:2402–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Lim ST, Chen XL, Lim Y, Hanson DA, Vo TT, Howerton K, et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell. 2008;29:9–22.CrossRefPubMedGoogle Scholar
  27. 27.
    Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, et al. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature. 1996;379:91–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Hannigan G, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer. 2005;5:51–63.CrossRefPubMedGoogle Scholar
  29. 29.
    Chase AJ, Bond M, Crook MF, Newby AC. Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol. 2002;22:765–71.CrossRefPubMedGoogle Scholar
  30. 30.
    Sato H, Kita M, Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem. 1993;268:23460–8.PubMedGoogle Scholar
  31. 31.
    Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 1993;8:395–405.PubMedGoogle Scholar
  32. 32.
    Taheri F, Bazan HE. Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2007;48:1931–41.CrossRefPubMedGoogle Scholar
  33. 33.
    Sen T, Dutta A, Maity G, Chatterjee A. Fibronectin induces matrix metalloproteainase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. Biochimie. 2010. doi:  10.1016/j.biochi.2010.07.005

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2010

Authors and Affiliations

  • Gargi Maity
    • 1
  • Paromita Roy Choudhury
    • 1
  • Triparna Sen
    • 1
  • Kirat Kumar Ganguly
    • 1
  • Hrishikesh Sil
    • 1
  • Amitava Chatterjee
    • 1
  1. 1.Department of Receptor Biology and Tumor MetastasisChittaranjan National Cancer InstituteKolkataIndia

Personalised recommendations